Summary by Moomoo AI
BeiGene announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22, 2024, succeeding Julia Wang. Rosenberg, 48, joins from Merck & Co., where he most recently served as Senior VP and Corporate Treasurer. He will receive a base salary of $620,000 with a 60% target bonus and equity awards valued at $5 million.Julia Wang, the current CFO, will resign effective July 19, 2024, and serve as Senior Advisor until August 31 to assist with the transition. Wang will receive severance benefits including 18 months of base salary ($930,000), target bonus, and accelerated vesting of certain equity awards.BeiGene CEO John V. Oyler highlighted the company's status as a top 15 global oncology innovator by revenue, with plans to have at least 10 new molecular entities this year. The company emphasized its continued focus on scaling its business and reinforcing global leadership in hematology while building franchises in other prevalent cancers.
